69 related articles for article (PubMed ID: 20546346)
1. Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: 'Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma'. Histopathology 2009; 54; 607-613.
Hsu JD; Yao CC; Yuan CC; Lai CR; Ting LT; Li YJ; Han CP
Histopathology; 2010 May; 56(6):810; author reply 810-1. PubMed ID: 20546346
[No Abstract] [Full Text] [Related]
2. Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma.
Naka T; Boltze C; Samii A; Samii M; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Kuester D; Roessner A
Histopathology; 2009 Apr; 54(5):607-13. PubMed ID: 19302530
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
[TBL] [Abstract][Full Text] [Related]
4. Anticytokeratin CAM5.2 is not synonymous with CK8/18 monoclonal antibody; and anticytokeratin CAM5.2 can be a marker for cytokeratin 8 but not for cytokeratin 18 and 19.
Han CP; Hsu JD; Li YJ
Am J Surg Pathol; 2010 Apr; 34(4):595; author reply 595-6, 596. PubMed ID: 20154593
[No Abstract] [Full Text] [Related]
5. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
6. Anti-cytokeratin CAM5.2 is not a monoclonal antibody against cytokeratin 8/18.
Hsu JD; Yao CC; Han LW; Han CP
Clin Exp Dermatol; 2010 Aug; 35(6):672-3. PubMed ID: 20337654
[No Abstract] [Full Text] [Related]
7. BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.
Liao CL; Tzeng SL; Hsu JD; Chen PJ; Han CP
Pathol Int; 2010 May; 60(5):417; author reply 418. PubMed ID: 20518894
[No Abstract] [Full Text] [Related]
8. Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).
Han CP; Hsu JD; Koo CL; Yang SF
Hum Pathol; 2010 Apr; 41(4):616-7; author reply 617. PubMed ID: 20226963
[No Abstract] [Full Text] [Related]
9. CAM5.2 (Becton Dickinson Biosciences) is not synonymous with CK8/18 (Leica Microsystems).
Wang KC; Hsu JD; Yao CC; Han CP
Cytopathology; 2010 Aug; 21(4):277-8; author reply 278. PubMed ID: 20345964
[No Abstract] [Full Text] [Related]
10. BD Pharmingen purified mouse anti-cytokeratin 7 monoclonal antibody (clone RCK105) should not be mistaken for BD Biosciences anti-cytokeratin CAM5.2 reagent (clone CAM 5.2).
Tseng CJ; Lin YH; Han CP
Am J Obstet Gynecol; 2011 Jan; 204(1):e14. PubMed ID: 21035782
[No Abstract] [Full Text] [Related]
11. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
[TBL] [Abstract][Full Text] [Related]
13. Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines.
Fujita J; Dobashi N; Ohtsuki Y; Ueda Y; Bandoh S; Yamadori I; Takahara J
Br J Cancer; 1999 Nov; 81(5):769-73. PubMed ID: 10555744
[TBL] [Abstract][Full Text] [Related]
14. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein.
Ostroumov E; Hunter CJ
Spine (Phila Pa 1976); 2008 Dec; 33(25):2774-80. PubMed ID: 19050584
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021".
Wang SC; Chen FL; Lin WL; Wang PH; Han CP
Cancer Chemother Pharmacol; 2011 Jan; 67(1):243-4; author reply 245. PubMed ID: 21153823
[No Abstract] [Full Text] [Related]
16. Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: "Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma", in J Cutan Pathol 2009; 36: 543.
Chen JT; Hsu JD; Yao CC; Han LW; Han CP
J Cutan Pathol; 2010 Oct; 37(10):1123-4. PubMed ID: 20175827
[No Abstract] [Full Text] [Related]
17. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
[TBL] [Abstract][Full Text] [Related]
18. The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18.
Cheng WC; Hsu JD; Yao CC; Han CP
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1674-5; author reply 1675. PubMed ID: 20494206
[No Abstract] [Full Text] [Related]
19. Intradural spinal seeding and fatal progression of a sacrococcygeal chordoma: a case report.
Ji T; Guo W; Shen DH; Yang Y; Tang S
Chin Med J (Engl); 2008 Jun; 121(12):1150-2. PubMed ID: 18706240
[No Abstract] [Full Text] [Related]
20. Differential expression of cytokeratin proteins during tumour progression in oral mucosa.
Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
Epithelial Cell Biol; 1994; 3(2):61-9. PubMed ID: 7528604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
